Back to today’s briefing

Story perspectives

Singapore and US Firms Unite to Revolutionize Genetic Medicine

5/12/2025

48 9

Summary

Story summary

Singapore's Nanyang Biologics and US-based Precisya Global Inc have joined forces to revolutionize the fight against genetic diseases. By merging PGI's cutting-edge genomic analytics with NYB's advanced AI, they aim to uncover nature-inspired treatments faster than ever, paving the way for personalized medicine that could change countless lives.

1 of 1

Story summary

Singapore's Nanyang Biologics and US-based Precisya Global Inc have joined forces to revolutionize the fight against genetic diseases. By merging PGI's cutting-edge genomic analytics with NYB's advanced AI, they aim to uncover nature-inspired treatments faster than ever, paving the way for personalized medicine that could change countless lives.